ep05-26 - 1
Original notice title
Fourniture de tocilizumab IV
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
25 / 100
Risk factors
No estimated value means bidders cannot gauge the potential contract size. The framework agreement may have a low ceili...
The minimum turnover requirement of EUR 150,000 in pharmaceutical supplies may be high for smaller suppliers. Tenderers...
Submission deadline in 13 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration 1 YEAR
- Supply of tocilizumab IV (pharmaceutical product) via a framework agreement
- Single lot, awarded to one tenderer
Show full summary
This is an open tender for a framework agreement for the supply of tocilizumab IV (pharmaceutical product) to the Centre Hospitalier Bois de l'Abbaye in Belgium. The contract is awarded based on lowest price only. Only one lot exists, with a duration of 1 year. The estimated contract value is not provided. The tender is published in French, and electronic submission is required. The deadline for submission is 7 July 2026 at 10:00 Brussels time.
Risks
No estimated value means bidders cannot gauge the potential contract size. The framework agreement may have a low ceili...
The minimum turnover requirement of EUR 150,000 in pharmaceutical supplies may be high for smaller suppliers. Tenderers...
Submission deadline in 13 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Price is the sole award criterion
Administrative
- Tenderers must submit an offer for the single lot
- Electronic submission is mandatory
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Name
Centre Hospitalier Bois de l'Abbaye
Location
Seraing, BEL
Website
Buyer profile
Identifier
0203980409_64
Lots (1)
LOT-0001
ep05-26 - 1
Framework agreement for the supply of tocilizumab IV to identified purchasing bodies. Single winner. Duration: 1 year.
Location
Duration
Category
Selection criteria
Deadline
Award details
Show original TED data
Original TED description
Objet: le marché est passé sous la forme d’un accord-cadre et a pour objet la fourniture de tocilizumab IV aux PAB identifiés ci-avant. Il s’agit d’un marché de fournitures ayant pour objet l’achat de produits. L’accord-cadre sera conclu avec un seul adjudicataire.
Procurement Details
- Publication date
- 03 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- French
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 382451-2026
- Source notice ID
- 77ff2856-cfda-4fe4-a449-d646da13bf6c
Documents (2)
Similar tenders
Denmark – Pharmaceutical products – Amgros 2027 1.1051.b
Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie
Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE
Denmark – Pharmaceutical products – Amgros 2027 1.1052.b
Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem
Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
25 / 100
Risk factors
No estimated value means bidders cannot gauge the potential contract size. The framework agreement may have a low ceili...
The minimum turnover requirement of EUR 150,000 in pharmaceutical supplies may be high for smaller suppliers. Tenderers...
Submission deadline in 13 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications